GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzymatica AB (FRA:EN9) » Definitions » Institutional Ownership

Enzymatica AB (FRA:EN9) Institutional Ownership : 0.02% (As of Dec. 13, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Enzymatica AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Enzymatica AB's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Enzymatica AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Enzymatica AB's Float Percentage Of Total Shares Outstanding is 0.00%.


Enzymatica AB Institutional Ownership Historical Data

The historical data trend for Enzymatica AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymatica AB Institutional Ownership Chart

Enzymatica AB Historical Data

The historical data trend for Enzymatica AB can be seen below:

2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30
Institutional Ownership 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02

Enzymatica AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Enzymatica AB Business Description

Traded in Other Exchanges
Address
Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.

Enzymatica AB Headlines

No Headlines